NPR Health
Trump signs order fast tracking review of psychedelics for mental health disorders
President Trump has signed an executive order to accelerate federal review of psychedelic compounds, including psilocybin and ibogaine, as potential treatments for mental health disorders. The move marks a significant shift in federal drug policy, fast-tracking regulatory scrutiny of substances that remain classified as Schedule I drugs. If approvals follow, it could open the door to a new class of treatments for conditions like depression and PTSD at a national scale.
Read article →
Stat News
STAT+: The race to catch KRAS, pancreatic cancer’s ‘greasy ball,’ and create the most promising drug in decades
Daraxonrasib, a KRAS-targeting drug developed by Revolution Medicines, is delivering results that researchers are calling the most significant advance in pancreatic cancer treatment in decades. In clinical data, the drug doubled survival time for patients with one of oncology's most notoriously difficult targets. The breakthrough challenges years of conventional wisdom that KRAS — long dubbed "undruggable" — was beyond therapeutic reach.
Read article →Medical Xpress
Cardiorespiratory fitness may cut dementia, depression and psychosis risk
Higher cardiorespiratory fitness — the heart and lungs' ability to deliver oxygen during sustained exercise — is emerging as a significant protective factor against serious mental health conditions including dementia, depression, and psychosis. The finding adds to a growing body of research confirming that physical and mental health are deeply intertwined. For clinicians and policymakers, it reinforces the case for treating cardiovascular fitness as a front-line tool in mental health prevention.
Read article →Guardian Health
Are you a woman who makes life easier for everyone else? Beware – you could endanger your health | Emma Beddington
A viral social media claim warns that women who are "too nice" risk developing autoimmune diseases — a statement with shaky scientific credentials but undeniable cultural traction. The idea taps into a growing body of research suggesting chronic stress and emotional suppression can have measurable effects on immune function. Whether or not the science holds up, the message is resonating because it names something real: the physical toll of relentless self-sacrifice.
Read article →Guardian Health
‘Oscar of science’ awarded to team behind gene therapy that restores lost vision
The team behind Luxturna — the first FDA-approved gene therapy for inherited blindness — has won the $3 million Breakthrough Prize, often dubbed the "Oscar of science." Developed over 25 years by molecular biologist Jean Bennett, ophthalmologist Albert Maguire, and physician Katherine High, the treatment has restored sight to patients who had never before seen their children's faces. The award recognizes a milestone in medicine that transforms gene therapy from theoretical promise into clinical reality.
Read article →Get this delivered every morning
Join thousands of readers who get the world's most important stories, curated daily.
Start reading free →